Connect Biopharma Holdings Limited — Form 6-K Summary
Reporting period: Form 6-K furnished June 17, 2022, reporting a Nasdaq notification received June 16, 2022. The company is a foreign private issuer filing annual reports on Form 20-F.
Business Context and Key Event
Nasdaq notified the company that its American Depositary Shares (ADSs) had closed below the required minimum bid price of $1.00 for 30 consecutive business days, constituting noncompliance with Nasdaq Listing Rule 5550(a)(2).
The ADSs continued to trade on the Nasdaq Global Market under the symbol CNTB, and the notification had no immediate effect on the listing or trading of the ADSs.
Financial Metrics and Liquidity
This filing does not provide revenue, earnings, cash flow, margins, debt, liquidity, or other operating or financial metrics.
Material Changes and Compliance Timeline
- Nasdaq granted an initial 180-calendar-day compliance period ending December 13, 2022.
- The company may regain compliance if its ADS bid price closes at or above $1.00 for at least 10 consecutive business days before the deadline.
- If compliance is not restored, the company may be eligible for an additional 180-day period, subject to transferring to the Nasdaq Capital Market and satisfying applicable market value, initial listing, and other requirements.
- If the company is not eligible or Nasdaq determines that compliance is unlikely, the ADSs may become subject to delisting proceedings.
Management Commentary, Risks, and Unusual Items
Management stated that it intends to monitor the ADS bid price and evaluate available options to regain compliance. The filing does not identify a specific remedial action, such as a reverse stock split.
Potential delisting would be subject to Nasdaq procedures and could be appealed, although the filing states that there is no assurance an appeal would succeed. The deficiency notice could adversely affect the continued Nasdaq listing and trading of the ADSs.
The report is incorporated by reference into the company’s Form F-3 and Form S-8 registration statements, except to the extent superseded by later filings.
Investor Verification Items
- Whether the ADS bid price reached at least $1.00 for the required 10 consecutive business days by December 13, 2022.
- Whether Nasdaq granted an additional compliance period or initiated delisting proceedings.
- Any corporate action taken to address the deficiency, including a potential reverse stock split or market transfer.
- The company’s subsequent financial condition, cash runway, and capital-raising needs, which are not addressed in this filing.